1. CTNI-30. LOGGIC/FIREFLY-2: A PHASE 3, RANDOMIZED TRIAL OF TOVORAFENIB VS. CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED LOW-GRADE GLIOMA HARBORING AN ACTIVATING RAF ALTERATION. (14th November 2022) Authors: van Tilburg, Cornelis; Jones, David T; Schmidt, Rene; Avula, Shivaram; van Meeteren, Antoinette Schouten-; Sehested, Astrid; Opocher, Enrico; Driever, Pablo Hernáiz; Witt, Ruth; Ziegler, David; Blackman, Samuel; Zhao, Xin; Tsao, Li-Pen; Cox, Michael; Hargrave, Darren; Witt, Olaf Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗